Thermo Fisher Scientific Total Assets increased by 2.7% to $113.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.4%, from $99.04B to $113.28B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 9.8% CAGR.
An increase suggests business expansion or acquisition activity, while a decrease may indicate asset divestiture or impairment.
The aggregate value of all economic resources owned by the company, including both current and non-current assets. This...
Varies significantly by industry; capital-intensive firms hold higher asset bases relative to revenue than service-oriented peers.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $67.70B | $73.60B | $95.12B | $92.75B | $90.58B | $90.54B | $97.15B | $94.66B | $94.11B | $97.06B | $98.73B | $97.10B | $98.50B | $100.36B | $97.32B | $99.04B | $101.23B | $103.02B | $110.34B | $113.28B |
| QoQ Change | — | +8.7% | +29.2% | -2.5% | -2.3% | -0.0% | +7.3% | -2.6% | -0.6% | +3.1% | +1.7% | -1.7% | +1.4% | +1.9% | -3.0% | +1.8% | +2.2% | +1.8% | +7.1% | +2.7% |
| YoY Change | — | — | — | — | +33.8% | +23.0% | +2.1% | +2.1% | +3.9% | +7.2% | +1.6% | +2.6% | +4.7% | +3.4% | -1.4% | +2.0% | +2.8% | +2.6% | +13.4% | +14.4% |
| Segment | Q4 '22 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Laboratory Products and Biopharma Services | — | — | — | — | — | $6.76B | $6.49B | $6.92B |
| Life Sciences Solutions | $21.85B | $3.19B | $3.21B | $2.98B | $3.02B | $3.55B | $3.45B | $3.49B |
| Analytical Instruments | $10.02B | $2.73B | $2.91B | $2.94B | $2.99B | $3.19B | $3.17B | $3.10B |
| Specialty Diagnostics | $5.54B | $1.15B | $1.23B | $1.22B | $1.30B | $1.31B | $1.32B | $1.33B |
| Laboratory Productsand Services | $51.28B | $51.09B | — | — | — | — | — | — |
| Total | $97.15B | $98.73B | $100.36B | $97.32B | $99.04B | $103.02B | $110.34B | $113.28B |
Laboratory Productsand Services was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.